tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
Holding RNAZ?
Track your performance easily

TransCode Therapeutics (RNAZ) Financial Statements

260 Followers

TransCode Therapeutics Financial Overview

TransCode Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.055; its P/E ratio is -0.04; TransCode Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.19M$ -3.34M$ -5.30M$ -4.33M$ -4.88M
EBITDA$ -5.04M$ -3.20M$ -5.16M$ -4.20M$ -4.78M
Net Income Common Stockholders$ -5.19M$ -3.33M$ -5.30M$ -4.34M$ -4.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.40M$ 4.90M$ 7.50M$ 3.60M$ 1.60M
Total Assets$ 4.82M$ 7.29M$ 10.23M$ 5.88M$ 5.59M
Total Debt$ 227.25K$ 339.41K$ 594.69K$ 663.29K$ 768.23K
Net Debt$ -3.17M$ -4.56M$ -6.91M$ -2.94M$ -831.77K
Total Liabilities$ 3.50M$ 2.71M$ 5.79M$ 3.79M$ 5.83M
Stockholders Equity$ 1.32M$ 4.58M$ 4.44M$ 2.09M$ -236.79K
Cash Flow-
Free Cash Flow$ -2.40M$ -3.90M-$ -4.41M$ -4.53M
Operating Cash Flow$ -2.40M$ -3.90M$ -3.51M$ -4.39M$ -4.51M
Investing Cash Flow$ -4.55K$ -3.84K$ -4.61K$ -18.11K$ -12.90K
Financing Cash Flow$ 785.20K$ 6.09M$ 7.39M$ 6.36M$ 1.18M
Currency in USD

TransCode Therapeutics Earnings and Revenue History

TransCode Therapeutics Debt to Assets

TransCode Therapeutics Cash Flow

TransCode Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis